Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma
NCT04340986 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1250
Last updated 2024-06-20
Summary
The main objective is to describe the evolution of patients treated for a primary malignant hepatobiliary tumor (hepatocellular carcinoma or cholangiocarcinoma) over the long course.
Conditions
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Marie LEQUOY, MD · AssistancePublique-Hôpitaux de Paris
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-02
- Primary Completion
- 2030-09-30
- Completion
- 2030-09-30
Countries
- France
Study Locations
More Related Trials
-
Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular Carcinoma
NCT03267641 ·Status: COMPLETED
-
Precision Medicine for Combined Hepatocellular-Cholangiocarcinoma
NCT06146127 ·Status: RECRUITING
-
Primary Hepatobiliary Cancer Cohort of Central China
NCT05520801 ·Status: RECRUITING
-
Endoarterial Treatment in Combination With Percutaneous Thermoablation for Medium-sized and Oligonodular Hepatocellular Carcinomas
NCT04172194 ·Status: COMPLETED
-
Liver Transplantation for Locally Advanced Intrahepatic Cholangiocarcinoma After SIRT and Chemotherapy
NCT06910722 ·Status: RECRUITING ·Phase: NA
-
Combined Therapy Using D-TACE, Gemcitabine and Cisplatin, and PD1 Antibody in Advanced and Unresectable Intrahepatic Cholangiocarcinoma
NCT05738057 ·Status: RECRUITING ·Phase: PHASE2
-
Sequential Treatment of Hepatocellular Carcinoma by Transarterial Chemoembolization and Local Ablation or External Radiation
NCT04813861 ·Status: COMPLETED
-
Transarterial Chemoembolization Plus Hypofractionnated Radiotherapy vs. Surgery in Locally Advanced Hepatocellular Carcinoma: an IPTW Comparison
NCT04823715 ·Status: COMPLETED
-
MEK162 in Combination With Capecitabine in Advanced Biliary Tract Cancer
NCT02773459 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Observational Study on Patients With Hepatocellular Carcinoma (HCC)
NCT04021056 ·Status: UNKNOWN
-
Liver Cancer Registry Platform
NCT04510740 ·Status: RECRUITING
-
International Registry on Cholangiocarcinoma Treatment
NCT01920503 ·Status: UNKNOWN
-
Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma
NCT00051532 ·Status: TERMINATED ·Phase: NA
-
FibroLamellar Carcinoma: an International Registry Study
NCT05730686 ·Status: UNKNOWN
-
Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards
NCT05681949 ·Status: UNKNOWN ·Phase: NA
-
Treatment of Advanced Intrahepatic Cholangiocarcinoma
NCT03940378 ·Status: UNKNOWN ·Phase: PHASE3
-
Liver Transplant Combined With Neoadjuvant Chemo-radiotherapy in the Treatment of Unresectable Hilar Cholangiocarcinoma. A Prospective Multicenter Study.
NCT04378023 ·Status: RECRUITING
-
Quality Of Life in Patients With Malignant Biliary Obstruction
NCT00579865 ·Status: COMPLETED
-
Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation
NCT06501625 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Adjuvant Hepatic Arterial Infusional Chemotherapy After Curative Resection of Hepatocellular Carcinoma
NCT01088581 ·Status: COMPLETED ·Phase: PHASE3
-
The Overall Survival of Patients With Unresectable HCC in Real-life
NCT03612726 ·Status: RECRUITING
-
Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma
NCT04993131 ·Status: RECRUITING ·Phase: NA
-
Ablative Chemoembolization for Unresectable and Large Hepatocellular Carcinoma
NCT03662841 ·Status: TERMINATED ·Phase: NA
-
Safety and Bioactivity of Ipilimumab and Nivolumab Combination Prior to Liver Resection in Hepatocellular Carcinoma
NCT03682276 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Pilot Study to Evaluate the Safety of a 3 Weeks Sitagliptin Treatment in HCC Patients Undergoing Liver Resection
NCT02650427 ·Status: COMPLETED ·Phase: PHASE1